Zika virus infection overview: Difference between revisions

Jump to navigation Jump to search
Nate Michalak (talk | contribs)
Nate Michalak (talk | contribs)
Line 25: Line 25:


==Natural History, Complications & Prognosis==
==Natural History, Complications & Prognosis==
Patients with Zika virus infection will develop symptoms between 3 and 12 days upon contracting the disease. Symptoms will typically begin with a mild headache and progress to include a macropapular rash spread across the body within 24 hours, followed by fever, malaise, and back pain. The symptoms typically last from 4-7 days and will fade and an alleviate by the end of a week. The prognosis is excellent, with a full recovery expected with minimal hospitalization and treatment limited to symptoms. Complications can arise through Congenital and Neurological disorders as a result of Zika virus infection; prognosis may be worse in the presence of these complications.


==Diagnosis==
==Diagnosis==

Revision as of 18:58, 17 December 2015

Sexually transmitted diseases Main Page

Zika virus infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Classification

Differentiating Zika Virus Infection from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Evaluation of Pregnant Women

Evaluation of Infants

Collection and Submission of Fetal Tissues

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Guidelines for Pregnant Women
Travel Notice
Blood Donation
Sexual transmission

Secondary Prevention

CDC Response Planning Tips

Risk-based Preparedness for States

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Zika virus infection overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Zika virus infection overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Zika virus infection overview

CDC on Zika virus infection overview

Zika virus infection overview in the news

Blogs on Zika virus infection overview

Directions to Hospitals Treating Zika virus infection

Risk calculators and risk factors for Zika virus infection overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nate Michalak, B.A.

Overview

Zika fever is an illness caused by the Zika virus, a member of the family Flaviviridae. The fever and virus are named after the Ugandan forest where the virus was first isolated. The virus is commonly found in Africa but has also been found in Malaysia and Micronesia. Symptoms are similar to dengue fever, but are milder in form and usually last four to seven days. No hemorrhagic manifestations have been documented. Common symptoms include a maculopapular skin rash that starts on the face or trunk before moving to the rest of the body, conjunctivitis, joint pain, low-grade fevers and headache.

Historical Perspective

Zika virus was first isolated from a rhesus Monkey in 1947 in Uganda. The virus was first isolated from humans in 1968 in Nigeria. Since then, outbreaks have occurred throughout Asia and Africa. The most recent outbreak occurred in Brazil in April 2015.

Pathophysiology

Causes

Zika virus infection is cause by Zika virus, an enveloped, single stranded positive sense RNA virus. Zika virus is a type of flavivirus and primarily transmitted through mosquitoes.

Classification

The illness caused by Zika virus is usually mild with symptoms lasting from several days to a week. Severe cases requiring hospitalization are uncommon.[1] A schema for classification of Zika virus infection is yet to be developed.

Differential Diagnosis

Epidemiology and Demographics

In 2015, Zika virus infection outbreaks rose dramatically, particularly in Brazil as observed by the manifestation of a correlated complication, microcephaly, in infants born to mothers with Zika virus infection, an incidence of 99.7/100,000 infants. The majority of Zika virus infection cases are reported in South Africa and Tropical Asia. As of 2014, Zika Virus infection outbreaks have become prevalent in South America as well. Cases reported in other regions of the world have come from infected travelers from areas experiencing outbreaks. Zika virus infection affects all age groups, with newborn infants particularly vulnerable due to risk of transmission from the mothers upon birth.

Risk Factors

Natural History, Complications & Prognosis

Patients with Zika virus infection will develop symptoms between 3 and 12 days upon contracting the disease. Symptoms will typically begin with a mild headache and progress to include a macropapular rash spread across the body within 24 hours, followed by fever, malaise, and back pain. The symptoms typically last from 4-7 days and will fade and an alleviate by the end of a week. The prognosis is excellent, with a full recovery expected with minimal hospitalization and treatment limited to symptoms. Complications can arise through Congenital and Neurological disorders as a result of Zika virus infection; prognosis may be worse in the presence of these complications.

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Biopsy

Treatment

Medical Therapy

Surgery

Prevention

References